Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/hemoperfusion-and-blood-purification-strategies-in-patients-with-covid-R1VludVhBu
References (80)
-
( Alharthy A , Faqihi F , Memish ZA , Balhamar A , Nasim N , Shahzad A , et al. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID‐19 plus acute kidney injury: a case‐series. Artif Organs. 2021;45:E101–12.33190288)
Alharthy A , Faqihi F , Memish ZA , Balhamar A , Nasim N , Shahzad A , et al. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID‐19 plus acute kidney injury: a case‐series. Artif Organs. 2021;45:E101–12.33190288Alharthy A , Faqihi F , Memish ZA , Balhamar A , Nasim N , Shahzad A , et al. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID‐19 plus acute kidney injury: a case‐series. Artif Organs. 2021;45:E101–12.33190288, Alharthy A , Faqihi F , Memish ZA , Balhamar A , Nasim N , Shahzad A , et al. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID‐19 plus acute kidney injury: a case‐series. Artif Organs. 2021;45:E101–12.33190288
-
W. Yu, M. Ding, G. Dai, C. Gu, L. Xue, Y. Chen, D. Zhou, J. Xian, H. Xu (2018)
[Analysis of 15 cases of avian influenza virus (H7N9) infection].Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 41 7
-
J Badulak, MV Antonini, CM Stead, L Shekerdemian, L Raman, ML Paden (2021)
Extracorporeal membrane oxygenation for COVID‐19: updated 2021 guidelines from the extracorporeal life support organization, 67
-
D. Katagiri, M. Ishikane, Y. Asai, S. Izumi, J. Takasaki, Hiyori Katsuoka, I. Kondo, S. Ide, Keiji Nakamura, T. Nakamoto, H. Nomoto, Y. Akiyama, Y. Miyazato, Tetsuya Suzuki, N. Kinoshita, Tatsunori Ogawa, T. Togano, Manabu Suzuki, M. Hashimoto, Keita Sakamoto, Y. Kusaba, T. Katsuno, T. Fukaya, M. Hojo, M. Sugiyama, M. Mizokami, T. Okamoto, A. Kimura, E. Noiri, N. Ohmagari, F. Hinoshita, H. Sugiyama (2020)
Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19Journal of Clinical Apheresis, 36
-
( Katagiri D , Ishikane M , Asai Y , Izumi S , Takasaki J , Katsuoka H , et al. Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19. J Clin Apheresis. 2021;36:313–21.33325084)
Katagiri D , Ishikane M , Asai Y , Izumi S , Takasaki J , Katsuoka H , et al. Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19. J Clin Apheresis. 2021;36:313–21.33325084Katagiri D , Ishikane M , Asai Y , Izumi S , Takasaki J , Katsuoka H , et al. Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19. J Clin Apheresis. 2021;36:313–21.33325084, Katagiri D , Ishikane M , Asai Y , Izumi S , Takasaki J , Katsuoka H , et al. Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19. J Clin Apheresis. 2021;36:313–21.33325084
-
A. Messina, F. Sanfilippo, A. Milani, L. Calabrò, Katerina Negri, M. García, M. Astuto, A. Vieillard-Baron, M. Cecconi (2021)
COVID-19-related echocardiographic patterns of cardiovascular dysfunction in critically ill patients: A systematic review of the current literatureJournal of Critical Care, 65
-
S. Friesecke, K. Träger, G. Schittek, Z. Molnár, Friedhelm Bach, K. Kogelmann, R. Bogdanski, Andreas Weyland, A. Nierhaus, F. Nestler, D. Olboeter, D. Tomescu, D. Jacob, H. Haake, E. Grigoryev, M. Nitsch, Arnd Baumann, M. Quintel, Matthias Schott, Jan Kielstein, A. Meier-Hellmann, F. Born, Ulrike Schumacher, Mervyn Singer, J. Kellum, F. Brunkhorst (2019)
International registry on the use of the CytoSorb® adsorber in ICU patientsMedizinische Klinik - Intensivmedizin und Notfallmedizin
-
A. Alharthy, Fahad Faqihi, Z. Memish, Abdullah Balhamar, Nasir Nasim, A. Shahzad, H. Tamim, S. Alqahtani, P. Brindley, D. Karakitsos (2020)
Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID‐19 plus acute kidney injury: A case‐seriesArtificial Organs, 45
-
( Swol J , Lorusso R . Additive treatment considerations in COVID‐19‐the clinician's perspective on extracorporeal adjunctive purification techniques. Artif Organs. 2020;44:918–25.32516506)
Swol J , Lorusso R . Additive treatment considerations in COVID‐19‐the clinician's perspective on extracorporeal adjunctive purification techniques. Artif Organs. 2020;44:918–25.32516506Swol J , Lorusso R . Additive treatment considerations in COVID‐19‐the clinician's perspective on extracorporeal adjunctive purification techniques. Artif Organs. 2020;44:918–25.32516506, Swol J , Lorusso R . Additive treatment considerations in COVID‐19‐the clinician's perspective on extracorporeal adjunctive purification techniques. Artif Organs. 2020;44:918–25.32516506
-
P. Sinha, C. Calfee, S. Cherian, D. Brealey, S. Cutler, C. King, C. Killick, O. Richards, Y. Cheema, C. Bailey, K. Reddy, K. Delucchi, M. Shankar-Hari, A. Gordon, M. Shyamsundar, C. O’Kane, D. McAuley, T. Szakmany (2020)
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational studyThe Lancet. Respiratory Medicine, 8
-
( Yu WQ , Ding MD , Dai GH , Gu CJ , Xue L , Chen Y , et al. Analysis of 15 cases of avian influenza virus (H7N9) infection. Intensive Care Med. 2018;41:534–8.)
Yu WQ , Ding MD , Dai GH , Gu CJ , Xue L , Chen Y , et al. Analysis of 15 cases of avian influenza virus (H7N9) infection. Intensive Care Med. 2018;41:534–8.Yu WQ , Ding MD , Dai GH , Gu CJ , Xue L , Chen Y , et al. Analysis of 15 cases of avian influenza virus (H7N9) infection. Intensive Care Med. 2018;41:534–8., Yu WQ , Ding MD , Dai GH , Gu CJ , Xue L , Chen Y , et al. Analysis of 15 cases of avian influenza virus (H7N9) infection. Intensive Care Med. 2018;41:534–8.
-
O. Abani, A. Abbas, F. Abbas, M. Abbas, Sadia Abbasi, H. Abbass, A. Abbott, N. Abdallah, A. Abdelaziz, M. Abdelfattah, B. Abdelqader, B. Abdul, A. Rasheed, A. Abdulakeem, R. Abdul-Kadir, A. Abdulmumeen, R. Abdul-Raheem, N. Abdulshukkoor, K. Abdusamad, Y. Khaleq, M. Abedalla, Abeer Amna, K. Abernethy, A. Aboaba, H. Abo-Leyah, A. Abou-Haggar, M. Abouibrahim, M. Abraham, T. Abraham, A. Abraheem, J. Abrams, Hyacinth-John Abu, A. Abu-Arafeh, S. Abubacker, A. Abung, Y. Aceampong, A. Achara, D. Acharya, S. Acheampong, J. Acheson, A. Acosta, C. Acton, J. Adabie-Ankrah, F. Adam, M. Adam, H. Adamali, C. Adams, C. Adams, K. Adams, R. Adams, T. Adams, K. Adcock, Jemaimah Addai, A. Adebiyi, K. Adegoke, V. Adell, Sherna Adenwalla, Oluwasegun Adesemoye, Emmanuel Adewunmi, J. Adeyemi, R. Adhikary, G. Adkins, A. Adnan, J. Aeron-Thomas, D. Affleck, C. Afnan, M. Afridi, Zainab Aftab, M. Agarwal, R. Agbeko, C. Agbo, P. Agent, S. Aggarwal, A. Aghababaie, S. Sadiq, Mohamed Nazeer, Mohammad Ahmad, Syed Ahmad, Asim Ahmed, B. Ahmed, F. Ahmed, H. Ahmed, Iram Ahmed, I. Ahmed, Khaled Ahmed, L. Ahmed, Mahin Ahmed, M. Ahmed, Muhammad Ahmed, Naseer Ahmed, N. Ahmed, O. Ahmed, R. Ahmed, Rizwan Ahmed, Saif Ahmed, Sammiya Ahmed, Sara Ahmed, S. Ahmed, S. Ahmed, R. Ali, Sana Ahmed, S. Ahmer, D. Ail, M. Ainsworth, M. Aissa, L. Aitken, B. Ajay, A. Ajibode, A. Ajmi, N. Akhtar, N. Akhtar, S. Akili, O. Akindolie, Y. Akinfenwa, O. Akinkugbe, O. Aktinade, Ahmad Aaraj, A. Balushi, M. Dakhola, A. Swaifi, E. Al-Abadi, N. Aladangady, A. Alam, S. Alam, A. Al-Asadi, K. Alatzoglou, P. Albert, L. Albon, G. Alcorn, S. Alcorn, A. Aldana, D. Alderdice, R. Aldouri, J. Aldridge, N. Aldridge, A. Alegria, A. Alexander, J. Alexander, Peter Alexander, Charlotte Alford, J. Al-fori, L. Alghazawi, B. Al-Hakim, S. Al-Hity, Ali Ali, Asad Ali, Fawzia Ali, J. Ali, Mariam Ali, Mohammad Ali, Nayab Ali, O. Ali, Sakina Ali, Syed Ali, A. Alina, F. Aliyuda, Katrin Alizaedeh, M. Al-Jibury, S. Al-Juboori, M. Al-Khalil, M. Alkhusheh, F. Allan, A. Allanson, R. Allcock, E. Allen, K. Allen, L. Allen, P. Allen, R. Allen, S. Allen, Sharon Allen, S. Allen, K. Allison, B. Allman, L. Allsop, H. Al-Moasseb, M. Al-Obaidi, L. Alomari, A. Al-Rabahi, B. Al-Ramadhani, Z. Al-Saadi, I. Alshaer, R. Salman, W. Al-Shamkhani, B. Al-Sheklly, S. Altaf, M. Alvarez, M. Alzetani, S. Amamou, N. Amar, S. Ambalavanan, Sarah-Jayne Ambler, R. Ambrogetti, Chris Ambrose, A. Ameen, K. Amenyah, M. Amezaga, A. Amin, Amina Amin, K. Amin, S. Amin, T. Amin, Amjad Amjad, N. Amjad, V. Amosun, K. Amsha, P. Amy, A. Anand, S. Anandappa, Julie Anderson, L. Anderson, Michelle Anderson, N. Anderson, R. Anderson, Rory Anderson, Wendy Anderson, P. Andreou, A. Andrews, Antonette Andrews, Jill Andrews, K. Aneke, A. Ang, W. Ang, T. Angel, A. Angela, P. Angelini, L. Anguvaa, O. Anichtchik, M. Anim-Somuah, K. Aniruddhan, Marie Ledingham, Jessica Annett, Patrick Anstey, R. Anstey, A. Anthony, A. Anthony-Pillai, P. Antill, Z. Antonina, V. Anu, M. Anwar, A. Apostolopoulos, D. Appleyard, M. Aquino, B. Araba, S. Aransiola, M. Araujo, A. Archer, D. Archer, S. Archer, C. Ardley, A. Arias, R. Arimoto, C. Arkley, C. Armah, I. Armata, A. Armitage, C. Armstrong, M. Armstrong, S. Armstrong, P. Armtrong, H. Arndt, C. Arnison-Newgass, D. Arnold, R. Arnold, D. Arora, K. Arora, P. Arora, R. Arora, A. Arter, A. Arya, R. Arya, D. Asandei, A. Asghar, C. Ashbrook-Raby, H. Ashby, J. Ashcroft, J. Ashcroft, S. Ashcroft, D. Asher, Ayesha Ashfaq, A. Ashish, S. Ashman-Flavell, S. Ashok, A. Ashour, M. Ashraf, S. Ashraf, Mohammad Ashraq, D. Ashton, S. Ashton, A. Ashworth, R. Ashworth, A. Aslam, H. Asogan, A. Asrar, Omar Assaf, R. Astin-Chamberlain, D. Athorne, B. Atkins, C. Atkins, S. Atkins, J. Atkinson, V. Atkinson, B. Atraskiewicz, A. Attia, Rita Atugonza, P. Aubrey, A. Aujayeb, A. Aung, H. Aung, K. Aung, Y. Aung, Z. Aung, E. Austin, K. Austin, Abdusshakur Auwal, M. Avery, J. Avis, G. Aviss, C. Avram, P. Avram, G. Awadzi, A. Awan, A. Aya, E. Ayaz, A. Ayers, J. Azam, M. Azharuddin, Ghazala Aziz, N. Aziz, A. Azkoul, A. Shah, G. Azzopardi, H. Azzoug, Fiyinfoluwa Babatunde, Melvin Babi, B. Babiker, G. Babington, M. Babirecki, M. Babores, Adetona Babs-Osibodu, S. Bacciarelli, R. Bachar, G. Bacon, J. Bacon, B. Badal, Gurpreet Badhan, S. Badhrinarayanan, Joseph Bae, Sibel Bafekr, A. Baggaley, A. Baggott, G. Bagley, D. Bagmane, L. Bagshaw, K. Bahadori, J. Bailey, K. Bailey, Lindsey Bailey, Liz Bailey, Morgan Bailey, Pippa Bailey, S. Bailey, H. Baillie, J. Baillie, J. Bain, V. Bains, D. Baird, S. Baird, T. Baird, Y. Baird, A. Bajandouh, Evelyn Baker, J. Baker, J. Baker, K. Baker, Rebecca Baker, T. Baker, V. Baker, H. Bakere, N. Bakerly, M. Baker-Moffatt, N. Bakhtiar, P. Bakoulas, Niranjan Balachandran, A. Balan, T. Balaskas, M. Balasubramaniam, A. Balcombe, A. Baldwin, A. Baldwin, C. Baldwin, D. Baldwin, R. Baldwin-Jones, J. Balfour, Ceri Ball, K. Ballard, I. Balluz, C. Balmforth, E. Balogh, A. Baluwala, G. Bambridge, A. Bamford, A. Bamford, P. Bamford, A. Bamgboye, E. Bancroft, H. Bancroft, T. Bancroft, J. Banda, K. Bandaru, S. Bandi, N. Bandla, S. Bandyopadhyam, A. Banerjee, R. Banerjee, H. Banks, Luke Banks, P. Banks, O. Bannister, L. Banton, M. Baptist, T. Baqai, A. Baral, D. Baramova, R. Barber, E. Barbon, M. Barbosa, J. Barbour, A. Barclay, C. Barclay, G. Bardsley, S. Bareford, S. Bari, A. Barker, D. Barker, H. Barker, Joseph Barker, L. Barker, Oliver Barker, K. Barker-Williams, S. Barkha, J. Barla, G. Barlow, R. Barlow, V. Barlow, J. Barnacle, Alex Barnard, D. Barnes, N. Barnes, T. Barnes, C. Barnetson, A. Barnett, M. Barnett, A. Barnett-Vanes, W. Barnsley, A. Barr, D. Barr, S. Barratt, M. Barrera, A. Barrett, F. Barrett, J. Barrett, J. Bartholomew, C. Bartlett, G. Bartlett, G. Barton, J. Barton, L. Barton, R. Barton, R. Baruah, S. Baryschpolec, A. Bashyal, B. Basker, A. Basoglu, J. Bassett, G. Bassett, C. Bassford, B. Bassoy, V. Bastion, A. Basumatary, T. Bate, Harry Bateman, K. Bateman, V. Bateman, E. Bates, H. Bates, Michelle Bates, Simon Bates, S. Batham, A. Batista, A. Batla, D. Batra, H. Batty, T. Batty, M. Baum, C. Bautista, F. Bawa, Fatima Bawani, S. Bax, M. Baxter (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialLancet (London, England), 397
-
( Villa G , Romagnoli S , De Rosa S , Greco M , Resta M , Pomarè Montin D , et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID‐19: a pilot study. Crit Care. 2020;24:605.33046113)
Villa G , Romagnoli S , De Rosa S , Greco M , Resta M , Pomarè Montin D , et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID‐19: a pilot study. Crit Care. 2020;24:605.33046113Villa G , Romagnoli S , De Rosa S , Greco M , Resta M , Pomarè Montin D , et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID‐19: a pilot study. Crit Care. 2020;24:605.33046113, Villa G , Romagnoli S , De Rosa S , Greco M , Resta M , Pomarè Montin D , et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID‐19: a pilot study. Crit Care. 2020;24:605.33046113
-
P. Garcia, M. Hilty, U. Held, E. Kleinert, M. Maggiorini (2021)
Cytokine adsorption in severe, refractory septic shockIntensive Care Medicine, 47
-
A. Gordon, P. Mouncey, F. Al-Beidh, K. Rowan, A. Nichol, Y. Arabi, D. Annane, A. Beane, Wilma Bentum-Puijk, L. Berry, Zahra Bhimani, M. Bonten, C. Bradbury, F. Brunkhorst, Adrian Buzgau, A. Cheng, M. Detry, E. Duffy, L. Estcourt, M. Fitzgerald, H. Goossens, R. Haniffa, A. Higgins, T. Hills, Christopher Horvat, F. Lamontagne, P. Lawler, H. Leavis, K. Linstrum, E. Litton, E. Lorenzi, J. Marshall, F. Mayr, D. McAuley, A. McGlothlin, S. McGuinness, B. McVerry, S. Montgomery, S. Morpeth, S. Murthy, Katrina Orr, R. Parke, Jane Parker, A. Patanwala, V. Pettilä, Emma Rademaker, Marlene Santos, Christina Saunders, C. Seymour, M. Shankar-Hari, W. Sligl, A. Turgeon, Anne Turner, F. Veerdonk, R. Zarychanski, Cameron Green, R. Lewis, D. Angus, C. McArthur, S. Berry, S. Webb, L. Derde (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 - Preliminary report -
D. Leisman, L. Ronner, R. Pinotti, Matthew Taylor, P. Sinha, C. Calfee, A. Hirayama, Fiore Mastroiani, C. Turtle, M. Harhay, M. Legrand, C. Deutschman (2020)
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromesThe Lancet. Respiratory Medicine, 8
-
( Leisman DE , Ronner L , Pinotti R , Taylor MD , Sinha P , Calfee CS , et al. Cytokine elevation in severe and critical COVID‐19: a rapid systematic review, meta‐analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233–44.33075298)
Leisman DE , Ronner L , Pinotti R , Taylor MD , Sinha P , Calfee CS , et al. Cytokine elevation in severe and critical COVID‐19: a rapid systematic review, meta‐analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233–44.33075298Leisman DE , Ronner L , Pinotti R , Taylor MD , Sinha P , Calfee CS , et al. Cytokine elevation in severe and critical COVID‐19: a rapid systematic review, meta‐analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233–44.33075298, Leisman DE , Ronner L , Pinotti R , Taylor MD , Sinha P , Calfee CS , et al. Cytokine elevation in severe and critical COVID‐19: a rapid systematic review, meta‐analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233–44.33075298
-
M. Schmidt, D. Hajage, G. Lebreton, A. Monsel, G. Voiriot, D. Levy, Ėlodie Baron, A. Beurton, J. Chommeloux, P. Meng, S. Nemlaghi, P. Bay, P. Leprince, A. Demoule, B. Guidet, J. Constantin, M. Fartoukh, M. Dres, A. Combes, Charles-Edouard A, C. Luyt, G. Hékimian, N. Brechot, M. Chambrun, C. Desnos, Jérémy Arzoine, E. Guérin, T. Schoell, P. Demondion, C. Juvin, Nathalie Nardonne, S. Marin, C. D’alessandro, Bao Nguyen, C. Quemeneur, A. James, Mona Assefi, V. Lepère, G. Savary, A. Gibelin, M. Turpin, Alexandre Elabbadi, E. Berti, C. Vézinet, Harold Bonvallot, P. Delmotte, Martin Sarcus, Charlotte Tour, Samia Abbas, É. Maury, J. Baudel, J. Lavillegrand, Hafid Oufella, A. Abdelkrim, Th Urbina, S. Virolle, Robin Deleris, Vincent Bonny, J. Marec, J. Mayaux, E. Morawiec (2020)
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort studyThe Lancet. Respiratory Medicine, 8
-
( Tachikawa R , Tomii K , Murase K , Ueda H , Harada Y , Kida Y , et al. Therapeutic effect of direct hemoperfusion with a polymyxin B‐immobilized fiber column in the treatment of HIV‐negative severe pneumocystis pneumonia. Respiration. 2011;81:318–24.20530959)
Tachikawa R , Tomii K , Murase K , Ueda H , Harada Y , Kida Y , et al. Therapeutic effect of direct hemoperfusion with a polymyxin B‐immobilized fiber column in the treatment of HIV‐negative severe pneumocystis pneumonia. Respiration. 2011;81:318–24.20530959Tachikawa R , Tomii K , Murase K , Ueda H , Harada Y , Kida Y , et al. Therapeutic effect of direct hemoperfusion with a polymyxin B‐immobilized fiber column in the treatment of HIV‐negative severe pneumocystis pneumonia. Respiration. 2011;81:318–24.20530959, Tachikawa R , Tomii K , Murase K , Ueda H , Harada Y , Kida Y , et al. Therapeutic effect of direct hemoperfusion with a polymyxin B‐immobilized fiber column in the treatment of HIV‐negative severe pneumocystis pneumonia. Respiration. 2011;81:318–24.20530959
-
R. Tachikawa, K. Tomii, K. Murase, H. Ueda, Y. Harada, Y. Kida, K. Ishihara (2010)
Therapeutic Effect of Direct Hemoperfusion with a Polymyxin B-Immobilized Fiber Column in the Treatment of HIV-Negative Severe Pneumocystis PneumoniaRespiration, 81
-
( Sinha P , Calfee CS , Cherian S , Brealey D , Cutler S , King C , et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID‐19: a prospective observational study. Lancet Respir Med. 2020;8:1209–18.32861275)
Sinha P , Calfee CS , Cherian S , Brealey D , Cutler S , King C , et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID‐19: a prospective observational study. Lancet Respir Med. 2020;8:1209–18.32861275Sinha P , Calfee CS , Cherian S , Brealey D , Cutler S , King C , et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID‐19: a prospective observational study. Lancet Respir Med. 2020;8:1209–18.32861275, Sinha P , Calfee CS , Cherian S , Brealey D , Cutler S , King C , et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID‐19: a prospective observational study. Lancet Respir Med. 2020;8:1209–18.32861275
-
( Ugurov P , Popevski D , Gramosli T , Neziri D , Vuckova D , Gjorgon M , et al. Early initiation of extracorporeal blood purification using the AN69ST (oXiris®) hemofilter as a treatment modality for COVID‐19 patients: a single‐centre case series. Braz J Cardiovasc Surg. 2020;1:1–13.)
Ugurov P , Popevski D , Gramosli T , Neziri D , Vuckova D , Gjorgon M , et al. Early initiation of extracorporeal blood purification using the AN69ST (oXiris®) hemofilter as a treatment modality for COVID‐19 patients: a single‐centre case series. Braz J Cardiovasc Surg. 2020;1:1–13.Ugurov P , Popevski D , Gramosli T , Neziri D , Vuckova D , Gjorgon M , et al. Early initiation of extracorporeal blood purification using the AN69ST (oXiris®) hemofilter as a treatment modality for COVID‐19 patients: a single‐centre case series. Braz J Cardiovasc Surg. 2020;1:1–13., Ugurov P , Popevski D , Gramosli T , Neziri D , Vuckova D , Gjorgon M , et al. Early initiation of extracorporeal blood purification using the AN69ST (oXiris®) hemofilter as a treatment modality for COVID‐19 patients: a single‐centre case series. Braz J Cardiovasc Surg. 2020;1:1–13.
-
P. Mehta, D. McAuley, Michael Brown, Emilie Sanchez, R. Tattersall, J. Manson (2020)
COVID-19: consider cytokine storm syndromes and immunosuppressionLancet (London, England), 395
-
( Mehta P , McAuley DF , Brown M , Sanchez E , Tattersall RS , Manson JJ . COVID‐19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–4.32192578)
Mehta P , McAuley DF , Brown M , Sanchez E , Tattersall RS , Manson JJ . COVID‐19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–4.32192578Mehta P , McAuley DF , Brown M , Sanchez E , Tattersall RS , Manson JJ . COVID‐19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–4.32192578, Mehta P , McAuley DF , Brown M , Sanchez E , Tattersall RS , Manson JJ . COVID‐19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–4.32192578
-
COVID-19 map -
S. Rosa, S. Cutuli, R. Ferrer, M. Antonelli, C. Ronco (2020)
Polymyxin B hemoperfusion in COVID-19 Patients with endotoxic shock: Case Series from EUPHAS II registry.Artificial organs
-
M. Zoller, Gundula Döbbeler, B. Maier, M. Vogeser, L. Frey, J. Zander (2015)
Can cytokine adsorber treatment affect antibiotic concentrations? A case report.The Journal of antimicrobial chemotherapy, 70 7
-
( Messina A , Sanfilippo F , Milani A , Calabrò L , Negri K , Monge García MI , et al. COVID‐19‐related echocardiographic patterns of cardiovascular dysfunction in critically ill patients: a systematic review of the current literature. J Crit Care. 2021;65:26–35.34082252)
Messina A , Sanfilippo F , Milani A , Calabrò L , Negri K , Monge García MI , et al. COVID‐19‐related echocardiographic patterns of cardiovascular dysfunction in critically ill patients: a systematic review of the current literature. J Crit Care. 2021;65:26–35.34082252Messina A , Sanfilippo F , Milani A , Calabrò L , Negri K , Monge García MI , et al. COVID‐19‐related echocardiographic patterns of cardiovascular dysfunction in critically ill patients: a systematic review of the current literature. J Crit Care. 2021;65:26–35.34082252, Messina A , Sanfilippo F , Milani A , Calabrò L , Negri K , Monge García MI , et al. COVID‐19‐related echocardiographic patterns of cardiovascular dysfunction in critically ill patients: a systematic review of the current literature. J Crit Care. 2021;65:26–35.34082252
-
( Grasselli G , Tonetti T , Protti A , Langer T , Girardis M , Bellani G , et al. Pathophysiology of COVID‐19‐associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201–8.32861276)
Grasselli G , Tonetti T , Protti A , Langer T , Girardis M , Bellani G , et al. Pathophysiology of COVID‐19‐associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201–8.32861276Grasselli G , Tonetti T , Protti A , Langer T , Girardis M , Bellani G , et al. Pathophysiology of COVID‐19‐associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201–8.32861276, Grasselli G , Tonetti T , Protti A , Langer T , Girardis M , Bellani G , et al. Pathophysiology of COVID‐19‐associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201–8.32861276
-
F. Sanfilippo, V. Rosa, M. Astuto (2020)
Micro-Thrombosis, Perfusion Defects, and Worsening Oxygenation in COVID-19 Patients: A Word of Caution on the Use of Convalescent PlasmaMayo Clinic Proceedings, 96
-
G. Villa, S. Romagnoli, S. Rosa, M. Greco, M. Resta, Diego Montin, Federico Prato, Francesco Patera, F. Ferrari, G. Rotondo, C. Ronco (2020)
Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot studyCritical Care, 24
-
( Dai X , Zhang Y , Yu L , Jiang Y‐A , Chen L , Chen YE , et al. Effect of artificial liver blood purification treatment on the survival of critical ill COVID‐19 patients. Artif Organs. 2021;45:762–9.33326621)
Dai X , Zhang Y , Yu L , Jiang Y‐A , Chen L , Chen YE , et al. Effect of artificial liver blood purification treatment on the survival of critical ill COVID‐19 patients. Artif Organs. 2021;45:762–9.33326621Dai X , Zhang Y , Yu L , Jiang Y‐A , Chen L , Chen YE , et al. Effect of artificial liver blood purification treatment on the survival of critical ill COVID‐19 patients. Artif Organs. 2021;45:762–9.33326621, Dai X , Zhang Y , Yu L , Jiang Y‐A , Chen L , Chen YE , et al. Effect of artificial liver blood purification treatment on the survival of critical ill COVID‐19 patients. Artif Organs. 2021;45:762–9.33326621
-
(2020)
Pathophysiology of COVID- 19associated acute respiratory distress syndrome: a multicentre prospective observational study -
(2021)
COVID- 19related echocardiographic patterns of cardiovascular dysfunction in critically ill patients: a systematic review of the current literature -
S. Hashemian, N. Shafigh, G. Afzal, H. Jamaati, P. Tabarsi, M. Marjani, M. Malekmohammad, Seyed Mortazavi, B. Khoundabi, D. Mansouri, A. Moniri, A. Hajifathali, E. Roshandel, E. Mortaz, I. Adcock (2020)
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)Pulmonology, 27
-
( Guo J , Xia H , Wang S , Yu L , Zhang H , Chen J , et al. The artificial‐liver blood‐purification system can effectively improve hypercytokinemia for COVID‐19. Artif Organs. 2020;11:586073.)
Guo J , Xia H , Wang S , Yu L , Zhang H , Chen J , et al. The artificial‐liver blood‐purification system can effectively improve hypercytokinemia for COVID‐19. Artif Organs. 2020;11:586073.Guo J , Xia H , Wang S , Yu L , Zhang H , Chen J , et al. The artificial‐liver blood‐purification system can effectively improve hypercytokinemia for COVID‐19. Artif Organs. 2020;11:586073., Guo J , Xia H , Wang S , Yu L , Zhang H , Chen J , et al. The artificial‐liver blood‐purification system can effectively improve hypercytokinemia for COVID‐19. Artif Organs. 2020;11:586073.
-
T Rampino, M Gregorini, L Perotti, F Ferrari, EF Pattonieri, MA Grignano (2021)
Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS‐CoV2 pneumonia, 50
-
( Schmidt M , Hajage D , Lebreton G , Monsel A , Voiriot G , Levy D , et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID‐19: a retrospective cohort study. Lancet Respir Med. 2020;8:1121–31.32798468)
Schmidt M , Hajage D , Lebreton G , Monsel A , Voiriot G , Levy D , et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID‐19: a retrospective cohort study. Lancet Respir Med. 2020;8:1121–31.32798468Schmidt M , Hajage D , Lebreton G , Monsel A , Voiriot G , Levy D , et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID‐19: a retrospective cohort study. Lancet Respir Med. 2020;8:1121–31.32798468, Schmidt M , Hajage D , Lebreton G , Monsel A , Voiriot G , Levy D , et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID‐19: a retrospective cohort study. Lancet Respir Med. 2020;8:1121–31.32798468
-
( Fajgenbaum DC , June CH . Cytokine storm. N Engl J Med. 2020;383:2255–73.33264547)
Fajgenbaum DC , June CH . Cytokine storm. N Engl J Med. 2020;383:2255–73.33264547Fajgenbaum DC , June CH . Cytokine storm. N Engl J Med. 2020;383:2255–73.33264547, Fajgenbaum DC , June CH . Cytokine storm. N Engl J Med. 2020;383:2255–73.33264547
-
L. Masiero, F. Procaccio, F. Vespasiano, F. Puoti, G. Bedeschi, M. Prugnoli, M. Antonini, S. Peverelli, A. Lombardo, S. Baroni, P. Fassini, G. Lanzillotti, F. Min, M. Donato, M. Sacchi, E. Masturzo, S. Vesconi, A. Troni, A. Montemurro, M. Cardillo (2023)
Workshop Purification Therapies – From Research to Clinical Evidence, Milan, Italy, September 30th – October 1st, 2022Blood Purification, 51
-
F. Zhou, Ting Yu, R. Du, Guohui Fan, Y. Liu, Zhibo Liu, J. Xiang, Ye-ming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, B. Cao (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyLancet (London, England), 395
-
A. Supady, Enya Weber, M. Rieder, Achim Lother, Tim Niklaus, Timm Zahn, Franziska Frech, Sissi Müller, M. Kuhl, C. Benk, S. Maier, G. Trummer, Annabelle Flügler, K. Krüger, Asieb Sekandarzad, P. Stachon, V. Zotzmann, C. Bode, P. Biever, D. Staudacher, T. Wengenmayer, E. Graf, D. Duerschmied (2021)
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trialThe Lancet. Respiratory Medicine, 9
-
G. Bozzi, D. Mangioni, F. Minoia, S. Aliberti, G. Grasselli, L. Barbetta, Valeria Castelli, E. Palomba, L. Alagna, A. Lombardi, R. Ungaro, C. Agostoni, M. Baldini, F. Blasi, M. Cesari, G. Costantino, A. Fracanzani, N. Montano, V. Monzani, A. Pesenti, F. Peyvandi, M. Sottocorno, A. Muscatello, G. Filocamo, A. Gori, A. Bandera (2020)
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort studyThe Journal of Allergy and Clinical Immunology, 147
-
( Bozzi G , Mangioni D , Minoia F , Aliberti S , Grasselli G , Barbetta L , et al. Anakinra combined with methylprednisolone in patients with severe COVID‐19 pneumonia and hyperinflammation: an observational cohort study. J Allergy Clin Immunol. 2021;147:561–6.e4.33220354)
Bozzi G , Mangioni D , Minoia F , Aliberti S , Grasselli G , Barbetta L , et al. Anakinra combined with methylprednisolone in patients with severe COVID‐19 pneumonia and hyperinflammation: an observational cohort study. J Allergy Clin Immunol. 2021;147:561–6.e4.33220354Bozzi G , Mangioni D , Minoia F , Aliberti S , Grasselli G , Barbetta L , et al. Anakinra combined with methylprednisolone in patients with severe COVID‐19 pneumonia and hyperinflammation: an observational cohort study. J Allergy Clin Immunol. 2021;147:561–6.e4.33220354, Bozzi G , Mangioni D , Minoia F , Aliberti S , Grasselli G , Barbetta L , et al. Anakinra combined with methylprednisolone in patients with severe COVID‐19 pneumonia and hyperinflammation: an observational cohort study. J Allergy Clin Immunol. 2021;147:561–6.e4.33220354
-
( Zhou F , Yu T , Du R , Fan G , Liu Y , Liu Z , et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.32171076)
Zhou F , Yu T , Du R , Fan G , Liu Y , Liu Z , et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.32171076Zhou F , Yu T , Du R , Fan G , Liu Y , Liu Z , et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.32171076, Zhou F , Yu T , Du R , Fan G , Liu Y , Liu Z , et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.32171076
-
( Zoller M , Döbbeler G , Maier B , Vogeser M , Frey L , Zander J . Can cytokine adsorber treatment affect antibiotic concentrations? A case report. J Antimicrob Chemother. 2015;70:2169–71.25786479)
Zoller M , Döbbeler G , Maier B , Vogeser M , Frey L , Zander J . Can cytokine adsorber treatment affect antibiotic concentrations? A case report. J Antimicrob Chemother. 2015;70:2169–71.25786479Zoller M , Döbbeler G , Maier B , Vogeser M , Frey L , Zander J . Can cytokine adsorber treatment affect antibiotic concentrations? A case report. J Antimicrob Chemother. 2015;70:2169–71.25786479, Zoller M , Döbbeler G , Maier B , Vogeser M , Frey L , Zander J . Can cytokine adsorber treatment affect antibiotic concentrations? A case report. J Antimicrob Chemother. 2015;70:2169–71.25786479
-
M. Gruda, Karl-Gustav Ruggeberg, P. O'sullivan, T. Guliashvili, A. Scheirer, T. Golobish, V. Capponi, P. Chan (2018)
Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beadsPLoS ONE, 13
-
J. Swol, R. Lorusso (2020)
Additive treatment considerations in COVID‐19 – the clinician´s perspective on extracorporeal adjunctive purification techniquesArtificial Organs
-
( Kowalewski M , Fina D , Słomka A , Raffa GM , Martucci G , Lo Coco V , et al. COVID‐19 and ECMO: the interplay between coagulation and inflammation‐a narrative review. Crit Care. 2020;24:205.32384917)
Kowalewski M , Fina D , Słomka A , Raffa GM , Martucci G , Lo Coco V , et al. COVID‐19 and ECMO: the interplay between coagulation and inflammation‐a narrative review. Crit Care. 2020;24:205.32384917Kowalewski M , Fina D , Słomka A , Raffa GM , Martucci G , Lo Coco V , et al. COVID‐19 and ECMO: the interplay between coagulation and inflammation‐a narrative review. Crit Care. 2020;24:205.32384917, Kowalewski M , Fina D , Słomka A , Raffa GM , Martucci G , Lo Coco V , et al. COVID‐19 and ECMO: the interplay between coagulation and inflammation‐a narrative review. Crit Care. 2020;24:205.32384917
-
( Gruda MC , Ruggeberg K‐G , O’Sullivan P , Guliashvili T , Scheirer AR , Golobish TD , et al. Broad adsorption of sepsis‐related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS ONE. 2018;13:e0191676.29370247)
Gruda MC , Ruggeberg K‐G , O’Sullivan P , Guliashvili T , Scheirer AR , Golobish TD , et al. Broad adsorption of sepsis‐related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS ONE. 2018;13:e0191676.29370247Gruda MC , Ruggeberg K‐G , O’Sullivan P , Guliashvili T , Scheirer AR , Golobish TD , et al. Broad adsorption of sepsis‐related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS ONE. 2018;13:e0191676.29370247, Gruda MC , Ruggeberg K‐G , O’Sullivan P , Guliashvili T , Scheirer AR , Golobish TD , et al. Broad adsorption of sepsis‐related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS ONE. 2018;13:e0191676.29370247
-
( Gordon AC , Mouncey PR , Al‐Beidh F , Rowan KM , Nichol AD , Arabi YM , et al. Interleukin‐6 receptor antagonists in critically ill patients with Covid‐19. N Engl J Med. 2021;384:1491–502.33631065)
Gordon AC , Mouncey PR , Al‐Beidh F , Rowan KM , Nichol AD , Arabi YM , et al. Interleukin‐6 receptor antagonists in critically ill patients with Covid‐19. N Engl J Med. 2021;384:1491–502.33631065Gordon AC , Mouncey PR , Al‐Beidh F , Rowan KM , Nichol AD , Arabi YM , et al. Interleukin‐6 receptor antagonists in critically ill patients with Covid‐19. N Engl J Med. 2021;384:1491–502.33631065, Gordon AC , Mouncey PR , Al‐Beidh F , Rowan KM , Nichol AD , Arabi YM , et al. Interleukin‐6 receptor antagonists in critically ill patients with Covid‐19. N Engl J Med. 2021;384:1491–502.33631065
-
S Friesecke, K Träger, GA Schittek, Z Molnar, F Bach, K Kogelmann (2019)
International registry on the use of the CytoSorb® adsorber in ICU patients: study protocol and preliminary results, 114
-
W. Brouwer, S. Duran, M. Kuijper, C. Ince (2019)
Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective studyCritical Care, 23
-
( De Rosa S , Cutuli SL , Ferrer R , Antonelli M , Ronco C . Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry. Artif Organs. 2021;45:E187–94.33377184)
De Rosa S , Cutuli SL , Ferrer R , Antonelli M , Ronco C . Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry. Artif Organs. 2021;45:E187–94.33377184De Rosa S , Cutuli SL , Ferrer R , Antonelli M , Ronco C . Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry. Artif Organs. 2021;45:E187–94.33377184, De Rosa S , Cutuli SL , Ferrer R , Antonelli M , Ronco C . Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry. Artif Organs. 2021;45:E187–94.33377184
-
G. Grasselli, T. Tonetti, A. Protti, T. Langer, M. Girardis, G. Bellani, J. Laffey, G. Carrafiello, L. Carsana, C. Rizzuto, A. Zanella, V. Scaravilli, G. Pizzilli, D. Grieco, Letizia Meglio, G. Pascale, E. Lanza, F. Monteduro, M. Zompatori, C. Filippini, F. Locatelli, M. Cecconi, R. Fumagalli, S. Nava, J. Vincent, M. Antonelli, Arthur Slutsky, A. Pesenti, V. Ranieri (2020)
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational studyThe Lancet. Respiratory Medicine, 8
-
( Horby P , Lim WS , Emberson JR , Mafham M , Bell JL , Linsell L . Dexamethasone in hospitalized patients with Covid‐19. N Engl J Med. 2021;384:693–704.32678530)
Horby P , Lim WS , Emberson JR , Mafham M , Bell JL , Linsell L . Dexamethasone in hospitalized patients with Covid‐19. N Engl J Med. 2021;384:693–704.32678530Horby P , Lim WS , Emberson JR , Mafham M , Bell JL , Linsell L . Dexamethasone in hospitalized patients with Covid‐19. N Engl J Med. 2021;384:693–704.32678530, Horby P , Lim WS , Emberson JR , Mafham M , Bell JL , Linsell L . Dexamethasone in hospitalized patients with Covid‐19. N Engl J Med. 2021;384:693–704.32678530
-
Jing Guo, H. Xia, Sheng Wang, Liang Yu, Huafen Zhang, Jun Chen, D. Shi, Yanfei Chen, Yan Zhang, Kaijin Xu, Xiaowei Xu, J. Sheng, Yunqing Qiu, Lanjuan Li (2020)
The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19Frontiers in Immunology, 11
-
AC Gordon, PR Mouncey, F Al‐Beidh, KM Rowan, AD Nichol, YM Arabi (2021)
Interleukin‐6 receptor antagonists in critically ill patients with Covid‐19, 384
-
( Supady A , Weber E , Rieder M , Lother A , Niklaus T , Zahn T , et al. Cytokine adsorption in patients with severe COVID‐19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open‐label, randomised, controlled trial. Lancet Respir Med. 2021;9:755–62.34000236)
Supady A , Weber E , Rieder M , Lother A , Niklaus T , Zahn T , et al. Cytokine adsorption in patients with severe COVID‐19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open‐label, randomised, controlled trial. Lancet Respir Med. 2021;9:755–62.34000236Supady A , Weber E , Rieder M , Lother A , Niklaus T , Zahn T , et al. Cytokine adsorption in patients with severe COVID‐19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open‐label, randomised, controlled trial. Lancet Respir Med. 2021;9:755–62.34000236, Supady A , Weber E , Rieder M , Lother A , Niklaus T , Zahn T , et al. Cytokine adsorption in patients with severe COVID‐19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open‐label, randomised, controlled trial. Lancet Respir Med. 2021;9:755–62.34000236
-
S. Hashemian, N. Shafigh, G. Afzal, H. Jamaati, E. Mortaz, P. Tabarsi, M. Marjani, M. Malekmohammad, F. Dastan, Seyed Mortazavi, M. Sadr, E. Idani, B. Khoundabi, A. Mohamadnia, A. Abedini, A. Kiani, A. Moniri, S. Nadji, Fatemeh Yassari, Mojtaba Dezfuli, M. Pourabdollah, M. Varahram, Faezeh Eshaghi, M. Malekpour, A. Velayati (2020)
Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 PatientsTanaffos, 19
-
( Brouwer WP , Duran S , Kuijper M , Ince C . Hemoadsorption with CytoSorb shows a decreased observed versus expected 28‐day all‐cause mortality in ICU patients with septic shock: a propensity‐score‐weighted retrospective study. Crit Care. 2019;23:317.31533846)
Brouwer WP , Duran S , Kuijper M , Ince C . Hemoadsorption with CytoSorb shows a decreased observed versus expected 28‐day all‐cause mortality in ICU patients with septic shock: a propensity‐score‐weighted retrospective study. Crit Care. 2019;23:317.31533846Brouwer WP , Duran S , Kuijper M , Ince C . Hemoadsorption with CytoSorb shows a decreased observed versus expected 28‐day all‐cause mortality in ICU patients with septic shock: a propensity‐score‐weighted retrospective study. Crit Care. 2019;23:317.31533846, Brouwer WP , Duran S , Kuijper M , Ince C . Hemoadsorption with CytoSorb shows a decreased observed versus expected 28‐day all‐cause mortality in ICU patients with septic shock: a propensity‐score‐weighted retrospective study. Crit Care. 2019;23:317.31533846
-
( Sanfilippo F , La Rosa V , Oliveri F , Astuto M . Convalescent plasma for COVID‐19: the risk of pulmonary embolism should not be underestimated! Crit Care. 2020;24:531.32859242)
Sanfilippo F , La Rosa V , Oliveri F , Astuto M . Convalescent plasma for COVID‐19: the risk of pulmonary embolism should not be underestimated! Crit Care. 2020;24:531.32859242Sanfilippo F , La Rosa V , Oliveri F , Astuto M . Convalescent plasma for COVID‐19: the risk of pulmonary embolism should not be underestimated! Crit Care. 2020;24:531.32859242, Sanfilippo F , La Rosa V , Oliveri F , Astuto M . Convalescent plasma for COVID‐19: the risk of pulmonary embolism should not be underestimated! Crit Care. 2020;24:531.32859242
-
M. Kowalewski, Dario Fina, Artur Słomka, G. Raffa, G. Martucci, V. Coco, M. Piero, M. Ranucci, P. Suwalski, R. Lorusso (2020)
COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative reviewCritical Care, 24
-
Masoumeh Asgharpour, Hamed Mehdinezhad, Masoumeh Bayani, M. Zavareh, S. Hamidi, R. Akbari, Reza Ghadimi, Ali Bijani, S. Mouodi (2020)
Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)BMC Nephrology, 21
-
( Wendel Garcia PD , Hilty MP , Held U , Kleinert E‐M , Maggiorini M . Cytokine adsorption in severe, refractory septic shock. Artif Organs. 2021;1:1–3.)
Wendel Garcia PD , Hilty MP , Held U , Kleinert E‐M , Maggiorini M . Cytokine adsorption in severe, refractory septic shock. Artif Organs. 2021;1:1–3.Wendel Garcia PD , Hilty MP , Held U , Kleinert E‐M , Maggiorini M . Cytokine adsorption in severe, refractory septic shock. Artif Organs. 2021;1:1–3., Wendel Garcia PD , Hilty MP , Held U , Kleinert E‐M , Maggiorini M . Cytokine adsorption in severe, refractory septic shock. Artif Organs. 2021;1:1–3.
-
( Friesecke S , Träger K , Schittek GA , Molnar Z , Bach F , Kogelmann K , et al. International registry on the use of the CytoSorb® adsorber in ICU patients: study protocol and preliminary results. Med Klin Intensivmed Notfallmed. 2019;114:699–707.)
Friesecke S , Träger K , Schittek GA , Molnar Z , Bach F , Kogelmann K , et al. International registry on the use of the CytoSorb® adsorber in ICU patients: study protocol and preliminary results. Med Klin Intensivmed Notfallmed. 2019;114:699–707.Friesecke S , Träger K , Schittek GA , Molnar Z , Bach F , Kogelmann K , et al. International registry on the use of the CytoSorb® adsorber in ICU patients: study protocol and preliminary results. Med Klin Intensivmed Notfallmed. 2019;114:699–707., Friesecke S , Träger K , Schittek GA , Molnar Z , Bach F , Kogelmann K , et al. International registry on the use of the CytoSorb® adsorber in ICU patients: study protocol and preliminary results. Med Klin Intensivmed Notfallmed. 2019;114:699–707.
-
( Center for Systems Science and Engineering at Johns Hopkins University . COVID‐19 map. [cited 2021 Sep 17]. Available from: https://coronavirus.jhu.edu/map.html )
Center for Systems Science and Engineering at Johns Hopkins University . COVID‐19 map. [cited 2021 Sep 17]. Available from: https://coronavirus.jhu.edu/map.htmlCenter for Systems Science and Engineering at Johns Hopkins University . COVID‐19 map. [cited 2021 Sep 17]. Available from: https://coronavirus.jhu.edu/map.html , Center for Systems Science and Engineering at Johns Hopkins University . COVID‐19 map. [cited 2021 Sep 17]. Available from: https://coronavirus.jhu.edu/map.html
-
( Hashemian SM , Shafigh N , Afzal G , Jamaati H , Tabarsi P , Marjani M , et al. Plasmapheresis reduces cytokine and immune cell levels in COVID‐19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2020;20:1–7.)
Hashemian SM , Shafigh N , Afzal G , Jamaati H , Tabarsi P , Marjani M , et al. Plasmapheresis reduces cytokine and immune cell levels in COVID‐19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2020;20:1–7.Hashemian SM , Shafigh N , Afzal G , Jamaati H , Tabarsi P , Marjani M , et al. Plasmapheresis reduces cytokine and immune cell levels in COVID‐19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2020;20:1–7., Hashemian SM , Shafigh N , Afzal G , Jamaati H , Tabarsi P , Marjani M , et al. Plasmapheresis reduces cytokine and immune cell levels in COVID‐19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2020;20:1–7.
-
( RECOVERY Collaborative Group . Tocilizumab in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label, platform trial. Lancet. 2021;397:1637–45.33933206)
RECOVERY Collaborative Group . Tocilizumab in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label, platform trial. Lancet. 2021;397:1637–45.33933206RECOVERY Collaborative Group . Tocilizumab in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label, platform trial. Lancet. 2021;397:1637–45.33933206, RECOVERY Collaborative Group . Tocilizumab in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label, platform trial. Lancet. 2021;397:1637–45.33933206
-
F. Sanfilippo, V. Rosa, Francesco Oliveri, M. Astuto (2020)
Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!Critical Care, 24
-
P. Ugurov, D. Popevski, T. Gramosli, D. Neziri, D. Vuckova, E. Stoicovski, Lidija Veljanovska-Kiridjievska, Katerina Ignevska, Sanja Mehandziska, Elena Ambarkova, Rodney Rosalia, Z. Mitrev (2020)
Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case SeriesBrazilian Journal of Cardiovascular Surgery, 37
-
( Rampino T , Gregorini M , Perotti L , Ferrari F , Pattonieri EF , Grignano MA , et al. Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS‐CoV2 pneumonia. Artif Organs. 2021;50:566–71.)
Rampino T , Gregorini M , Perotti L , Ferrari F , Pattonieri EF , Grignano MA , et al. Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS‐CoV2 pneumonia. Artif Organs. 2021;50:566–71.Rampino T , Gregorini M , Perotti L , Ferrari F , Pattonieri EF , Grignano MA , et al. Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS‐CoV2 pneumonia. Artif Organs. 2021;50:566–71., Rampino T , Gregorini M , Perotti L , Ferrari F , Pattonieri EF , Grignano MA , et al. Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS‐CoV2 pneumonia. Artif Organs. 2021;50:566–71.
-
Dai Xia-hong, Yimin Zhang, Yu-guo Liang, Jiang Ying-An, Chen Liang, C. Ye, L. Ming, Gao Chunming, S. Jia, Xiang Shulin, Lian YongGuo, Li Jianzhou, Zhou Chenliang, Zhou Xiaoyang, C. Nan, Li Yuanchun, L. Jing, Zhang Yuanyuan, Cheng Xiaobei, Z. Danhua, Gao Hainv, Tang Lingling, Zhuo Mengfei, Lanjuan Li (2020)
Effect of artificial liver blood purification treatment on the survival of critical ill COVID‐19 patientsArtificial Organs, 45
-
(2021)
Polymyxin B hemoperfusion in coronavirus disease 2019 patients with 1476 | HEMOPERFUSION IN COVID- 19 endotoxic shock: case series from EUPHAS2 registry -
( Asgharpour M , Mehdinezhad H , Bayani M , Zavareh MSH , Hamidi SH , Akbari R , et al. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID‐19). BMC Nephrol. 2020;21:1–10.)
Asgharpour M , Mehdinezhad H , Bayani M , Zavareh MSH , Hamidi SH , Akbari R , et al. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID‐19). BMC Nephrol. 2020;21:1–10.Asgharpour M , Mehdinezhad H , Bayani M , Zavareh MSH , Hamidi SH , Akbari R , et al. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID‐19). BMC Nephrol. 2020;21:1–10., Asgharpour M , Mehdinezhad H , Bayani M , Zavareh MSH , Hamidi SH , Akbari R , et al. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID‐19). BMC Nephrol. 2020;21:1–10.
-
D. Fajgenbaum, C. June (2020)
Cytokine StormThe New England Journal of Medicine, 383
-
N. Popa-Fotea (2021)
Dexamethasone in Hospitalized Patients with Covid-19Romanian Archives of Microbiology and Immunology, 80
-
(2021)
Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry -
Jenelle Badulak, M. Antonini, Christine Stead, L. Shekerdemian, Lakshmi Raman, M. Paden, C. Agerstrand, R. Bartlett, N. Barrett, A. Combes, R. Lorusso, T. Mueller, Mark Ogino, G. Peek, V. Pellegrino, A. Rabie, Leonardo Salazar, M. Schmidt, K. Shekar, G. MacLaren, D. Brodie (2021)
ECMO for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization (ELSO).ASAIO journal
-
( Badulak J , Antonini MV , Stead CM , Shekerdemian L , Raman L , Paden ML , et al. Extracorporeal membrane oxygenation for COVID‐19: updated 2021 guidelines from the extracorporeal life support organization. ASAIO J. 2021;67:485–95.33657573)
Badulak J , Antonini MV , Stead CM , Shekerdemian L , Raman L , Paden ML , et al. Extracorporeal membrane oxygenation for COVID‐19: updated 2021 guidelines from the extracorporeal life support organization. ASAIO J. 2021;67:485–95.33657573Badulak J , Antonini MV , Stead CM , Shekerdemian L , Raman L , Paden ML , et al. Extracorporeal membrane oxygenation for COVID‐19: updated 2021 guidelines from the extracorporeal life support organization. ASAIO J. 2021;67:485–95.33657573, Badulak J , Antonini MV , Stead CM , Shekerdemian L , Raman L , Paden ML , et al. Extracorporeal membrane oxygenation for COVID‐19: updated 2021 guidelines from the extracorporeal life support organization. ASAIO J. 2021;67:485–95.33657573
- Publisher
- Wiley
- Copyright
- © 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.
- ISSN
- 0160-564X
- eISSN
- 1525-1594
- DOI
- 10.1111/aor.14078
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Artificial Organs – Wiley
Published: Dec 1, 2021
Keywords: artificial liver; blood purification; Cytosorb; hemoadsorption; inflammation; interleukin‐6; mortality; oXiris; Toraymyxin